Altimmune, Inc. (0A4C.L)

7.20 +0.01 (+0.07%) At close: 06:41PM BST

Altimmune, Inc.

910 Clopper Road
Suite 201S
Gaithersburg, MD 20878
United States
240 654 1450
https://altimmune.com

Sector(s): 
Industry: 
Full-time employees: 59

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Vipin K. Garg Ph.D.	President, CEO & Director	986.14k	N/A	1958
Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS	Chief Medical Officer	681.81k	N/A	1953
Mr. Raymond M. Jordt M.B.A.	Chief Business Officer	578.85k	N/A	1973
Mr. Richard I. Eisenstadt M.B.A.	Chief Financial Officer	619.69k	N/A	1958
Mr. Bertrand Georges Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Dr. M. Scot Roberts Ph.D.	Chief Scientific Officer	599.25k	N/A	1959
Mr. Tony Blandin B.S.	Vice President of Quality & Compliance Management	N/A	N/A	N/A
Mr. Andrew Shutterly M.S.	Corporate Controller	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Corporate governance

Altimmune, Inc.’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 7; Board: 3; Shareholder rights: 4; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.